Artal Group S.A. - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 79 filers reported holding ARCUS BIOSCIENCES INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q2 2019$2,147,000
-42.7%
270,000
-10.0%
0.09%
-43.1%
Q1 2019$3,747,000
+16.0%
300,0000.0%0.15%
+27.5%
Q4 2018$3,231,000
-22.7%
300,0000.0%0.12%
+10.1%
Q3 2018$4,182,000
+13.9%
300,0000.0%0.11%
+39.7%
Q2 2018$3,672,000
-20.7%
300,0000.0%0.08%
+34.5%
Q1 2018$4,632,000300,0000.06%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q2 2019
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$50,877,00022.64%
Octagon Capital Advisors LP 2,489,974$78,584,00016.99%
Decheng Capital Management III (Cayman), LLC 869,790$27,451,0008.41%
BVF INC/IL 3,960,948$125,008,0005.00%
PFM Health Sciences, LP 3,431,010$108,283,0004.05%
EcoR1 Capital, LLC 3,265,101$103,047,0003.22%
Alphabet Inc. 2,563,441$80,902,0002.62%
Boxer Capital, LLC 1,432,200$45,200,0002.32%
SECTORAL ASSET MANAGEMENT INC 338,480$10,682,0001.90%
PARK CIRCLE Co 64,000$2,020,0001.68%
View complete list of ARCUS BIOSCIENCES INC shareholders